By Topic

The use of prompt γ-rays for in-vivo dosimetry at therapeutic proton and ion beams

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

8 Author(s)
F. Fiedler ; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiation Physics, P.O.B. 510119, D-01314, Germany ; U. Dersch ; C. Golnik ; T. Kormoll
more authors

Radiation therapy is an important treatment modality in cancer therapy. New radiation species like protons and light ions have the potential of increasing tumor conformity of the irradiation. These particle beams offer advantages over conventional treatment modalities, such as photons. Because of the way particles deposit their energy on their path through tissue they allow for an increased dose deposition in the tumor volume and reduce the damage to the surrounding healthy tissue. However, the parameters of the ion beams must be calculated from X-ray CT data using a physical beam model. Minor inaccuracies of imaging and modeling and small changes in the irradiated volume will lead to a mismatch of the deposited dose maximum and the tumor. This causes missing dose in the tumor volume and potential damage to healthy tissue. Thus, to use the advantages of particle therapy to full capacity, proton and ion beam radiotherapy treatment requires efficient quality assurance techniques for dose delivery monitoring. Until now, the only clinically applied in-vivo dosimetry method for ion beams is PET. However, this method suffers from inherent physical limitations. Therefore, a new approach based on the detection of prompt gamma rays is under development. A Compton camera seems to be a feasible technical solution for monitoring proton and ion irradiation. Our project is aimed to design and construct such a camera, and evaluate if it could lead to clinical applications. This comprises the whole simulation process, i.e. simulating the expected gamma-emissions from the treatment plan, the reconstruction and the assembly of a prototype as well as the simulation of the detector efficiency.

Published in:

Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC), 2011 IEEE

Date of Conference:

23-29 Oct. 2011